Sort
51,570 grants matching “autoimmune disease”
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
$533,912Kenneth Michael Pollard · Scripps Research Institute, The · R01 · FY2024 · ES
Autoimmunity and Immunopathology Training Program
$533,882Mark J Shlomchik · University Of Pittsburgh At Pittsburgh · T32 · FY2023 · AI
miR-21 regulation of autoreactive B cell and lupus nephritis development
$533,851Ziaur Rahman · Thomas Jefferson University · R01 · FY2025 · AI
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
$533,831Tomoshige Kino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Innate Immunity: Signal Transduction and Interferon Gene Regulation
$533,802Thomas P Maniatis · Harvard University · R01 · FY2010 · AI
Unmasking the Immunomodulatory Roles of CD7 Signaling
$533,768Wan-Lin Lo · University Of Utah · R01 · FY2023 · AI
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$533,743Amy E Moran · Oregon Health & Science University · R37 · FY2023 · CA
Human Blood Monocyte Receptor Expression and Modulation
$533,701Alan D Schreiber · University Of Pennsylvania · R01 · FY2008 · AI
Modulation of HIV-specific CD8+ T and B cell function by CD4+ T helper responses
$533,655Hendrik Streeck · Massachusetts General Hospital · R01 · FY2011 · AI
Development and Application of New Ionization Methods for Biological Mass Spectrometry
$533,545David C. Muddiman · North Carolina State University Raleigh · R01 · FY2023 · GM
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
$533,398Yuri Sergeev · National Eye Institute · ZIA · FY2014 · EY
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,358Anton Wellstein · Georgetown University · R01 · FY2021 · CA
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,344Anton Wellstein · Georgetown University · R01 · FY2020 · CA
Role of IL-12 family cytokines in human autoimmune Uveitis
$533,284Charles E Egwuagu · National Eye Institute · ZIA · FY2018 · EY
NF-kappaB: Orchestration of the Inflammatory Response
$533,281David Baltimore · California Institute Of Technology · R01 · FY2009 · GM
Functional analyses of human and mouse SLAMF - SLAMF2 receptor/ligand interactio
$533,275Arlene H Sharpe · Beth Israel Deaconess Medical Center · P01 · FY2014 · AI
Functional analyses of human and mouse SLAMF - SLAMF2 receptor/ligand interactio
$533,275Arlene H Sharpe · Beth Israel Deaconess Medical Center · P01 · FY2015 · AI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
$533,260Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · AI
MENOPAUSE, IDDM, AND AUTOIMMUNITY--THE FAD STUDY
$533,247University Of Pittsburgh At Pittsburgh · R01 · FY2000 · DK
Transcriptional Regulation of Innate-Like T Cells
$533,233Albert S. Bendelac · University Of Chicago · R37 · FY2022 · AI
Transcriptional Regulation of Innate-Like T Cells
$533,233Daria Esterhazy · University Of Chicago · R01 · FY2024 · AI
Harnessing the anti-inflammatory activity of extracellular sialylation of IgG.
$533,224Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2025 · AI
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,211Anton Wellstein · Georgetown University · R01 · FY2018 · CA
Oklahoma Rheumatic Disease Research Core Centers
$533,200Judith A James · Oklahoma Medical Research Foundation · P30 · FY2008 · AR
Oklahoma Rheumatic Disease Research Core Centers
$533,200Judith A James · Oklahoma Medical Research Foundation · P30 · FY2007 · AR